Logo for the Ask a Healer Wellness Library

FDA Prescription Drug Recalls
Recalled Drugs in 2010

Home > Search > Privacy > Contact > Health Articles

generic drugs > is lipitor safe? > natural statin drugs alternatives

Ask a Healer Prescription Drugs Series

Image links to EarthCalm EMF Protection Review
My personal review of
Earth Calm EMF Protection

Link to personal review of blis probiotic lozenges
My personal review of
Therabreath Probiotics
with blis K12 and M18

Partial List of FDA-Recalled Drug and Products for 2010

Info compiled by

Related information:
More Prescription Drug Recalls

The FDA's Drug Recalls Page

FDA Throws Baby Out With Bath Water

This is an old entry. I've found a page on the FDA site that lists current recalls here: FDA Drug Recalls

Drug and company names on the recall list for 2018 include Taytulla, X-Jow, Acne Shave, MBI Distributing, Inc., 7K and Poseidon, Apotex Corporation, AuroMedics Pharma LLC, AMA Wholesale Inc., Premier Pharmacy Labs, PASTA DE LASSAR ANDROMACO, MarcasUSA, LLC, etc. Visit the website for much more detail on type of products recalled in 2018. There are about 25 on the list as of May, 2018, for 2018 alone.

Previous Post of older recalled drugs:
This is a partial list of the drugs and products recalled or amended by FDA in 2010. If your drug is on the list, visit the link at the end of the article for more info on any recall that may affect you.

Actos (pioglitazone):
Ongoing Safety Review -
Potential Increased Risk of Bladder Cancer

Angiotensin Receptor Blockers (ARBs):
Ongoing Safety Review for Cancer Risk

Arava (leflunomide): Boxed Warning
Risk of Severe Liver Injury

Aromatase Inhibitors in Products
Marketed as Dietary Supplements: Recall

Avandia (rosiglitazone):
REMS - Risk of Cardiovascular Events

Avandia (rosiglitazone):
Ongoing Review of Cardiovascular Safety

Benicar (olmesartan):
Ongoing Safety Review

Bisphosphonates (Osteoporosis Drugs):
Label Change - Atypical Fractures Update

Coumadin 1 mg Tablet Blister Packs:
Recall: Physician Sample Blister Packs:

Lot# 9A48931A, 9A48931B, 9A48931C, expiration January 2012; HUD Blister Pack: Lot# 8F34006B, 8K44272A, 8K46168A, 9F44437A and 9K58012B with expiry dates between June 2011 and November 2012

Cubicin (daptomycin):
Drug Safety Communication
Risk of Eosinophilic Pneumonia

Epogen and Procrit (epoetin alfa):
Recall - Particulate Matter in Vials

Erythropoiesis-Stimulating Agents (ESAs):
Procrit, Epogen and Aranesp: Drug Safety Communication

Evamist (estradiol transdermal spray): Drug Safety Communication
Unintended Exposure of Children and Pets to Topical Estrogen

Exjade (deferasirox):
Boxed Warning

Fentanyl Transdermal System: Recall
Potential for Active Ingredient to Release Faster Than Specified
Control/Lot # 30041 Expiration 12/2011
Control/Lot # 30049 Expiration 12/2011
Control/Lot # 30066 Expiration 12/2011
Control/Lot # 30096 Expiration 01/2012
Control/Lot # 30097 Expiration 02/2012
Control/Lot # 30123 Expiration 01/2012
Control/Lot # 30241 Expiration 02/2012
Control/Lot # 30256 Expiration 02/2012
Control/Lot # 30257 Expiration 03/2012
Control/Lot # 30258 Expiration 03/2012
Control/Lot # 30349 Expiration 03/2012
Control/Lot # 30350 Expiration 03/2012
Control/Lot # 30391 Expiration 03/2012
Control/Lot # 30392 Expiration 04/2012
Control/Lot # 30429 Expiration 04/2012
Control/Lot # 30430 Expiration 04/2012
Control/Lot # 30431 Expiration 04/2012
Control/Lot # 30517 Expiration 04/2012

Gadolinium-based Contrast Agents: Class Labeling Change - Risk of Nephrogenic Systemic Fibrosis

GnRH Agonists: Label Change
Increased Risk of Diabetes and Cardiovascular Disease (Update)

GnRH Agonists:
Safety Review of Drug Class Used to Treat Prostate Cancer

Invirase (saquinavir):
Label Change - Risk of Abnormal Heart Rhythm

Invirase (saquinavir):
Ongoing safety review of clinical trial data

Lamictal (lamotrigine):
Label Change - Risk of Aseptic Meningitis

Lipitor (atorvastatin)
40 mg: Recall Specific Bottles
This recall was due to the lipitor having an odor. They never say, on the website, what caused the odor. They say they've identified it and are "implementing rigorous measures" working to stop it. I'd like to know what cause it, thank you very much. I'd also like a little more assurance for my mom and others who take lipitor than "A medical assessment has determined that the odor is not likely to cause adverse health consequences in patients taking LIPITOR.". Not likely? How not likely?

Long-Acting Beta-Agonists (LABAs):
New Safe Use Requirements

McNeil Consumer Healthcare
Over-the-Counter Infants’ and Children’s Products:

Meridia (sibutramine):
Market Withdrawal Due to Risk of Serious Cardiovascular Events

Midodrine hydrochloride:
FDA Proposes Withdrawal of Low Blood Pressure Drug
Update: FDA backed off this so ProAmatine is still, as far as I know, being prescribed even though there are questions about effectiveness.

Nimodipine Oral Capsules:
Medication Errors - IV Administration May Result in Death, Serious Harms

Oral Bisphosphonates:
Ongoing Safety Review of Atypical Subtrochanteric Femur Fracture

PediaCare Children's Products [Blacksmith Brand]:
Recall of four products

Plavix (clopidogrel):
Reduced effectiveness in patients who are poor metabolizers of the drug

Promacta (eltrombopag):
Portal Venous System Thromboses in Study of Patients With Chronic Liver Disease

Withdrawal - Risk of Cardiac Toxicity

Qualaquin (quinine sulfate):
New Risk Evaluation and Mitigation Strategy
Risk of serious hematological reactions

Rapamune (sirolimus):
Drug Monitoring Recommendations

Stalevo (entacapone/carbidopa/levodopa):
Ongoing Safety Review

Stalevo(carbidopa/levodopa and entacapone):
Ongoing Safety Review: Possible increased cardiovascular risk

Tygacil (tigecycline):
Label Change - Increased Mortality Risk

Tylenol 8 Hour Caplets 50 Count: Recall

Valcyte (valganciclovir hydrochloride)
Label Change: Possible overdose in pediatric patients

Velcade (bortezomib):
Starting Dose Adjustments for
Patients with Hepatic Impairment

Videx/Videx EC (didanosine):
Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension

Vivitrol (naltrexone for extended-release injectable suspension):
Medication Guide Required for Patients

Zocor (simvastatin):
Increased risk of muscle injury with high doses

There were quite a few other products recalled because of particulate matter, which is just a gentle way of saying there was something in there that had no business being there. In some cases, there were glass particles; in others stainless steel particles or actual contaminants. It would have taken me days to detail all of those so visit the FDA page listed below for more info on those recalls. Here's just one example:

Hospira Brand Liposyn and Propofol:
Recall - From what I read the Liposyn has stainless steel particles in it, in the recalled batches.

How did you get that staph infection in the hospital? ~*~ Off-Label Prescribing 2

Health Disclaimer: The information listed here was up to date at time I checked the FDA website. Information changes all the time so for most current drug recall updates, please visit the FDA recall page linked earlier. The opinions expressed on this page are my own, and not presented as replacement for your own investigation and research.